Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
315 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (11)
  • Currently Recruiting (8)
  • (-) Closed (3)

Medical Condition

  • Show all (1630)
  • Addiction (14)
  • Allergy, Asthma, & Immunology (12)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (26)
  • Blood Disorders (37)
  • Bone & Muscle (8)
  • Cancer (662)
  • Child Development (4)
  • COVID-19 (Coronavirus) (28)
  • Critical Illness (1)
  • Diabetes (15)
  • Ear, Nose and Throat (5)
  • Endocrine & Metabolic Disease (11)
  • Eye (7)
  • Gastrointestinal and Digestive Diseases (21)
  • Hair and Skin Disorders (1)
  • Headaches (5)
  • Healthy Volunteers (140)
  • Heart Disease (109)
  • Infectious Disease (37)
  • Insomnia (2)
  • Kidney Disease (12)
  • Liver Disease (40)
    • Cirrhosis of the Liver (4)
    • Hepatic Encephalopathy (2)
    • Hepatitis (11)
    • (-) Liver Failure (1)
    • NASH (3)
  • Lung Disease (29)
  • Meniere's Disease (1)
  • Neurological Disorders (139)
  • Nutrition (6)
  • (-) Obesity (2)
  • Obstetrics & Gynecology (43)
  • Pain Management (1)
  • Pediatrics (83)
  • Psychiatric Disorders (59)
  • Rehabilitation (7)
  • Stroke (5)
  • Surgery (7)
  • Transplant (37)
  • Urology (4)
  • Vascular Conditions (9)
Displaying 1 - 3 of 3

Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)

Condition: Liver Disease / Liver Failure
Investigator: Elizabeth Verna, MD
Status: Closed
The purpose of this research study is to determine if an investigational drug, VS-01, will help in the treatment of acute-on-chronic liver failure (ACLF) compared to supportive care (standard of therapy). ACLF is a potentially life-threatening condition characterized by a group of signs that occur together (syndrome) in patients with a late stage of…
Read More

Lowering Insulin to Decrease Liver Fat Production

Condition: Obesity
Investigator: Joshua Cook, MD, PhD
Status: Closed
We are conducting a research study on the effect of high insulin levels on the buildup of excessive liver fat ("fatty liver disease") in people at risk for type 2 diabetes. We are seeking adult volunteers, ages 18-65, who have obesity with a body mass index of 30-45, and have been diagnosed with, or are at risk for, prediabetes and metabolic…
Read More

Pancreatic Clamp Study: Lowering Insulin Levels During Temporary Insulin Resistance

Condition: Obesity
Investigator: Joshua Cook, MD, PhD
Status: Closed
We're conducting a research study on how much insulin is needed to control blood sugar in people who are made temporarily resistant to insulin's effects. Insulin is the main hormone (chemical signal) that the body uses to lower the levels of sugar in the blood. We are interested in looking at insulin levels because we think that lowering insulin…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science